NCT00287066终止3 期
Open-Label Randomized Two-Way Crossover Pilot Study To Estimate The Effects Of Inhaled Versus IV Infusion Of Human Insulin With Regards To Glucose Disposal In Subjects With Type 1 Diabetes Mellitus
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 终止
- 发起方
- Pfizer
- 入组人数
- 22
- 试验地点
- 1
- 主要终点
- 18F-labeled glucose uptake in muscle
研究概览
简要总结
To assess the impact of inhalation of insulin on glucose disposition in patients with type 1 diabetes
详细描述
The study was terminated on Oct. 28, 2007. The protocol was undergoing implementation and methodological issues with major revisions that qualified this trial as a new trial. Pfizer decided to cancel new trials because of the decision to withdraw Exubera due to lack of market performance and not for safety reasons.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Diabetes mellitus Type 1
排除标准
- •Asthma, COPD
结局指标
主要结局
18F-labeled glucose uptake in muscle
次要结局
- Glucose turnover overnight Insulin pharmacokinetics
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Efficacy & Safety of Inhaled Insulin in Type 1 DiabetesDiabetes, Type INCT00308308Mannkind Corporation589
已完成
3 期
A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose ControlDiabetes MellitusNCT00134147Pfizer1,100
已完成
1 期
Study on the Effects on Blood Glucose Following Intradermal and Subcutaneous Dosing of Insulin in Diabetic PatientsDiabetesNCT01120444Becton, Dickinson and Company20
终止
3 期
A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes MellitusDiabetes Mellitus Type 2NCT00282971Pfizer354
已完成
1 期
A Pilot Study to Assess the Safety, PK and PD of Insulin Injected Via MicronJet or Conventional NeedleIntradermal InjectionsNCT00602914NanoPass Technologies Ltd23